zepbound tirzepatide weight loss news

FDA, Zepbound and obstructive sleep apnea

The shortage of popular weight loss drug tirzepatide is over, FDA says. Patients could see higher costs as a result.

The weight loss medication tirzepatide (Mounjaro and Zepbound) is no longer in shortage, according to the FDA. Access to cheaper versions could end.

People on MSN · 2d

Zepbound Weight Loss Medication Approved by FDA to Treat Sleep Apnea

The Food and Drug Administration (FDA) announced the approval of the weight loss drug Zepbound, generically known as tirzepatide, to help people treat obstructive sleep apnea.

Hosted on MSN · 4d

Lilly Rises on FDA Approval of Weight-Loss Drug Zepbound for Sleep Apnea

Key Takeaways Eli Lilly's Zepbound has been approved by the Food and Drug Administration (FDA) as a treatment for adults with sleep apnea and obesity, the drugmaker said after the bell Friday.Trials of the Lilly drug found that it helped reduce the number of breathing disruptions in an average night of sleep.

KSL1d

Lilly's weight-loss treatment Zepbound becomes first FDA-approved drug for sleep apnea

Zepbound and Lilly's widely used diabetes drug, Mounjaro, both chemically called tirzepatide, belong to a class of drugs ...

rheumatologyadvisor16d

Tirzepatide Bests Semaglutide in Head-to-Head Weight Loss Trial

The most common adverse events reported with both treatments were mild to moderate gastrointestinal-related side effects.

ABC News20d

Zepbound users discuss weight loss after preliminary research touts effectiveness

Zepbound is a medication containing tirzepatide, which the preliminary study showed to be more effective for weight loss than Wegovy, which contains semaglutide. This preliminary study ...

Medical News Today17d

Average weight loss on Zepbound

Research consistently suggests people with overweight or obesity have more average weight loss on Zepbound than a placebo. The active ingredient in Zepbound is tirzepatide, which falls into ...

Time23d

Which Weight-Loss Drug Is Better: Wegovy or Zepbound?

Wegovy (semaglutide) and Zepbound (tirzepatide) both target a group ... was linked to more weight loss than Wegovy, but until now, no studies have compared the two medications directly.

FOX59 News23d

Lilly's Zepbound® (tirzepatide) superior to Wegovy® (semaglutide) in head-to-head trial showing an average weight loss of 20.2% vs. 13.7%

Zepbound ® (tirzepatide) provided a 47% greater relative weight loss compared to Wegovy ® (semaglutide). On average, Zepbound led to a superior weight loss of 20.2% compared to 13.7% ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results